Zerbaxa
Active Ingredient(s): Ceftolozane + TazobactamFDA Approved: * December 19, 2014
Pharm Company: * CUBIST PHARMS INC
Category: Antibiotics
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Zerbaxa Overview
Ceftolozane/tazobactam, sold under the brand name Zerbaxa, is a combination antibiotic used for the treatment of complicated urinary tract infections and complicated intra-abdominal infections in adults.[2][3][4] Ceftolozane is a cephalosporin antibiotic, developed for the treatment of infections with gram-negative bacteria that are resistant to conventional antibiotics.[5] It was studied for urinary tract infections, intra-abdom...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ceftolozane
Recent Zerbaxa Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Ceftolozane + Tazobactam
- Injection: 1g/0.5g
- Powder: 1gm/vial + 0.5gm/vial
NDC Database Records for Zerbaxa: (1 result)
Sorted by National Drug Code- 67919-030 Zerbaxa Intravenous Injection, Powder, Lyophilized, for Solution by Cubist Pharmaceuticals, Inc.
Drugs with one or more similar ingredients: (3 results)
- CEFTOLOZANE + TAZOBACTAM
- PIPERACILLIN + TAZOBACTAM
- ZOSYN Piperacillin + Tazobactam2 discussions